glucagon receptor retatrutide Is better than tirzepatide? Triple vs dual agonist compared retatrutide peptide | peptidesskin

K.MatovA.et al (2017)

Avoiding excessive dosing to reduce side effects

Thus, GLP-1 analogues, such as exenatide and liraglutide, and the DPP-4 inhibitors which lower glucose levels by GLP-1 mediated effects, appear to have a very low incidence of hypoglycemia in clinical trials (Figure 13.6)

So in addition to being a standalone disease, so obesity has this connection

In AWARD-10 [31], a 24-week, randomized, double-blind, placebo-controlled trial evaluating once-weekly dulaglutide (administered at either 1.5 or 0.75 mg) as add-on therapy to SGLT2is in a total of 424 patients with inadequately controlled T2DM, only one episode of severe hypoglycemia was reported throughout the study, in a patient treated with dulaglutide 0.75 mg, confirming the very low incidence of serious hypoglycemia with GLP-1RAs in combination with SGLT2is [31]